BHVN
Biohaven·NYSE
--
--(--)
--
--(--)
5.11 / 10
Netural
Fund flow profile is strong (7.8/10) with positive small, block, and extra-large inflows, though medium and large flows are negative. Analyst consensus is overwhelmingly bullish (Buy rating from 2 analysts, 100% Buy), but historical win rates vary (0% for RBC Capital, 75% for Morgan Stanley). Sentiment is neutral, and the recent price trend is falling, creating a mixed signal for traders.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-21
InstitutionRBC Capital
Times predicted5
Historical Win Rate0.0%
What is the analyst consensus for BHVN?
- BHVN holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.11/10 (Netural).
